Engineers Gate Manager LP Neogenomics Inc Transaction History

Engineers Gate Manager LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $216,606 - $384,769	18,561 Added 39.26%	65,837 $1.07 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $574,403 - $843,876	47,276 New	47,276 $581,000
Q4 2022 Feb 14, 2023	BUY	$6.45 - $12.07 $24,897 - $46,590	3,860 Added 11.73%	36,776 $339,000
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $2.07 Million - $3.41 Million	-263,821 Reduced 88.91%	32,916 $283,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $562,018 - $1.11 Million	79,606 Added 36.66%	296,737 $2.42 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $2.64 Million - $7.66 Million	217,131 New	217,131 $2.64 Million
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $1.11 Million - $1.74 Million	-58,327 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $546,602 - $750,149	-28,588 Reduced 32.89%	58,327 $1.12 Million
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $1.7 Million - $2.09 Million	86,915 New	86,915 $1.91 Million

291

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.84B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.